ALB and hepatocellular carcinoma: Non-invasive assessment of liver disease, for instance, using liver stiffness measurement, can further add significant additional information, as recently shown in a cohort of patients with advanced chronic liver disease in whom liver stiffness measurement (LSM) and albumin levels following SVR could identify patients at higher or lower risk of HCC [34].